Prothrombin complex concentrate for vitamin K antagonist reversal in traumatic intracranial hemorrhage

Objective - Administration of prothrombin complex concentrate (PCC) is recommended for vitamin K antagonist (VKA) reversal in patients with severe bleeding complications. However, there are only limited data available on its use for VKA reversal in patients with traumatic intracranial hemorrhage (IC...

Full description

Saved in:
Bibliographic Details
Main Authors: Beynon, Christopher (Author) , Nofal, Mohammed (Author) , Rizos, Timolaos (Author) , Laible, Mona (Author) , Sakowitz, Oliver (Author) , Unterberg, Andreas (Author)
Format: Article (Journal)
Language:English
Published: 6 August 2020
In: Journal of clinical neuroscience
Year: 2020, Volume: 79, Pages: 197-202
ISSN:1532-2653
DOI:10.1016/j.jocn.2020.07.006
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jocn.2020.07.006
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S0967586820313436
Get full text
Author Notes:Christopher Beynon, Mohammed Nofal, Timolaos Rizos, Mona Laible, Oliver W. Sakowitz, Andreas W. Unterberg

MARC

LEADER 00000caa a2200000 c 4500
001 1738989577
003 DE-627
005 20240407193451.0
007 cr uuu---uuuuu
008 201118s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.jocn.2020.07.006  |2 doi 
035 |a (DE-627)1738989577 
035 |a (DE-599)KXP1738989577 
035 |a (OCoLC)1341377776 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Beynon, Christopher  |d 1980-  |e VerfasserIn  |0 (DE-588)136046258  |0 (DE-627)57442931X  |0 (DE-576)300798806  |4 aut 
245 1 0 |a Prothrombin complex concentrate for vitamin K antagonist reversal in traumatic intracranial hemorrhage  |c Christopher Beynon, Mohammed Nofal, Timolaos Rizos, Mona Laible, Oliver W. Sakowitz, Andreas W. Unterberg 
264 1 |c 6 August 2020 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 18.11.2020 
520 |a Objective - Administration of prothrombin complex concentrate (PCC) is recommended for vitamin K antagonist (VKA) reversal in patients with severe bleeding complications. However, there are only limited data available on its use for VKA reversal in patients with traumatic intracranial hemorrhage (ICH). - Methods - Data from all anticoagulated patients referred to our hospital for treatment of traumatic ICH and who received PCC for anticoagulation reversal were retrospectively analysed with specific focus on bleeding and thromboembolic complications during the further in-hospital course. - Results - A total of 142 patients were included in the present study. The median age was 78 years (Interquartile range [IQR]: 72-84) and the median Glasgow Coma Scale (GCS) score on admission was 12 (IQR: 7-14). Median International Normalized Ratio (INR) on admission was 2.5 [IQR: 2.0-3.3] and decreased to 1.2 [IQR: 1.1-1.3] following administration of a median dose of 2000 I.U. PCC [IQR: 1500-2625]. The in-hospital mortality rate was 13% and the median GCS of survivors at discharge was 14 [IQR: 12-15]. Thromboembolic events after PCC administration occurred in 4 patients (2.8%). The overall one-year mortality rate in this patient cohort was 49%. - Conclusions - PCC administration rapidly normalises INR and facilitates urgent neurosurgical procedures in anticoagulated patients with traumatic ICH. 
650 4 |a Coagulopathy 
650 4 |a Emergency medicine 
650 4 |a Hemostasis 
650 4 |a Intracranial hemorrhage 
650 4 |a Warfarin 
700 1 |a Nofal, Mohammed  |d 1987-  |e VerfasserIn  |0 (DE-588)1112232672  |0 (DE-627)866226176  |0 (DE-576)476450055  |4 aut 
700 1 |a Rizos, Timolaos  |d 1973-  |e VerfasserIn  |0 (DE-588)129478458  |0 (DE-627)470187891  |0 (DE-576)297680536  |4 aut 
700 1 |a Laible, Mona  |d 1980-  |e VerfasserIn  |0 (DE-588)140709592  |0 (DE-627)620899174  |0 (DE-576)320401146  |4 aut 
700 1 |a Sakowitz, Oliver  |d 1971-  |e VerfasserIn  |0 (DE-588)123767075  |0 (DE-627)706419928  |0 (DE-576)293869189  |4 aut 
700 1 |a Unterberg, Andreas  |e VerfasserIn  |0 (DE-588)1032681187  |0 (DE-627)738641200  |0 (DE-576)168441233  |4 aut 
773 0 8 |i Enthalten in  |t Journal of clinical neuroscience  |d Burlington, Mass. : Harcourt, 1994  |g 79(2020), Seite 197-202  |h Online-Ressource  |w (DE-627)320476235  |w (DE-600)2009190-4  |w (DE-576)264627431  |x 1532-2653  |7 nnas  |a Prothrombin complex concentrate for vitamin K antagonist reversal in traumatic intracranial hemorrhage 
773 1 8 |g volume:79  |g year:2020  |g pages:197-202  |g extent:6  |a Prothrombin complex concentrate for vitamin K antagonist reversal in traumatic intracranial hemorrhage 
856 4 0 |u https://doi.org/10.1016/j.jocn.2020.07.006  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S0967586820313436  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201118 
993 |a Article 
994 |a 2020 
998 |g 1032681187  |a Unterberg, Andreas  |m 1032681187:Unterberg, Andreas  |d 910000  |d 911200  |e 910000PU1032681187  |e 911200PU1032681187  |k 0/910000/  |k 1/910000/911200/  |p 6  |y j 
998 |g 123767075  |a Sakowitz, Oliver  |m 123767075:Sakowitz, Oliver  |d 50000  |e 50000PS123767075  |k 0/50000/  |p 5 
998 |g 140709592  |a Laible, Mona  |m 140709592:Laible, Mona  |d 910000  |d 911100  |e 910000PL140709592  |e 911100PL140709592  |k 0/910000/  |k 1/910000/911100/  |p 4 
998 |g 129478458  |a Rizos, Timolaos  |m 129478458:Rizos, Timolaos  |d 910000  |d 911100  |e 910000PR129478458  |e 911100PR129478458  |k 0/910000/  |k 1/910000/911100/  |p 3 
998 |g 1112232672  |a Nofal, Mohammed  |m 1112232672:Nofal, Mohammed  |d 910000  |d 911200  |e 910000PN1112232672  |e 911200PN1112232672  |k 0/910000/  |k 1/910000/911200/  |p 2 
998 |g 136046258  |a Beynon, Christopher  |m 136046258:Beynon, Christopher  |d 910000  |d 911200  |e 910000PB136046258  |e 911200PB136046258  |k 0/910000/  |k 1/910000/911200/  |p 1  |x j 
999 |a KXP-PPN1738989577  |e 3806527121 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"eki":["320476235"],"zdb":["2009190-4"],"issn":["1532-2653"]},"part":{"volume":"79","year":"2020","extent":"6","pages":"197-202","text":"79(2020), Seite 197-202"},"pubHistory":["1.1994 -"],"recId":"320476235","origin":[{"publisher":"Harcourt","dateIssuedDisp":"1994-","publisherPlace":"Burlington, Mass.","dateIssuedKey":"1994"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Journal of clinical neuroscience","title":"Journal of clinical neuroscience"}],"disp":"Prothrombin complex concentrate for vitamin K antagonist reversal in traumatic intracranial hemorrhageJournal of clinical neuroscience","note":["Ungezählte Beil. ersch. als \"A\"-Nr. zusätzlich zur H.-Zählung"]}],"title":[{"title_sort":"Prothrombin complex concentrate for vitamin K antagonist reversal in traumatic intracranial hemorrhage","title":"Prothrombin complex concentrate for vitamin K antagonist reversal in traumatic intracranial hemorrhage"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"eki":["1738989577"],"doi":["10.1016/j.jocn.2020.07.006"]},"physDesc":[{"extent":"6 S."}],"person":[{"display":"Beynon, Christopher","role":"aut","family":"Beynon","given":"Christopher"},{"display":"Nofal, Mohammed","role":"aut","family":"Nofal","given":"Mohammed"},{"role":"aut","display":"Rizos, Timolaos","given":"Timolaos","family":"Rizos"},{"role":"aut","display":"Laible, Mona","given":"Mona","family":"Laible"},{"role":"aut","display":"Sakowitz, Oliver","given":"Oliver","family":"Sakowitz"},{"display":"Unterberg, Andreas","role":"aut","family":"Unterberg","given":"Andreas"}],"language":["eng"],"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"6 August 2020"}],"note":["Gesehen am 18.11.2020"],"name":{"displayForm":["Christopher Beynon, Mohammed Nofal, Timolaos Rizos, Mona Laible, Oliver W. Sakowitz, Andreas W. Unterberg"]},"recId":"1738989577"} 
SRT |a BEYNONCHRIPROTHROMBI6202